Tourmaline Bio Inc. (TRML NASDAQ) stock market data APIs
$47.8213
-0.04(-0.1%)
as of October 17, 2025
Try our APIs with
free plan!
Tourmaline Bio Inc. Financial Data Overview
Price chart is built with
Anychart
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
Prev. Close
47.8213
Open
47.7843
High
47.9805
Low
47.7757
52 wk Range
11.56-48.27
Market Cap
1 231 M
Shares Outstanding
25 692 K
EPS
-1.79
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tourmaline Bio Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tourmaline Bio Inc. data using free add-ons & libraries
Get Tourmaline Bio Inc. Fundamental Data
Tourmaline Bio Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -102 406 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-13
- EPS/Forecast: -0.91
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tourmaline Bio Inc. News
New
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated (NYSE - CMA), Veeco Instruments Inc. (Nasdaq - VECO), Tourmaline Bio, Inc. (Nasdaq - TRML)
BALA CYNWYD, Pa., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ...
NVS Reports Positive Late-Stage Data on Kidney Disease Drug
Novartis NVS recently announced positive final results from the late-stage, APPLAUSE-IgAN, study on Fabhalta (iptacopan) in adults living with IgA nephropathy (IgAN), a progressive autoimmune kidney d...
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRML, CCRD, PBBK on Behalf of Shareholders
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or bre...
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate Merger – TRML, PNFP, MRCC, and UNP
NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholder...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
